Related Experiment Video
Updated: Aug 6, 2026
11:00
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
PANoptosis and Immune Remodeling in the Tumor Microenvironment
Fangyu Liu1, Xuanyi Zhou1, Zihan Liu1
1School of Clinical Medicine, Beijing University of Chinese Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China.
Summary
PANoptosis, a novel cell death pathway, promotes inflammation and influences tumor microenvironment dynamics. Understanding its role is key for developing new cancer immunotherapies.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- PANoptosis, a newly identified programmed cell death, combines features of apoptosis, necroptosis, and pyroptosis.
- It is implicated in promoting inflammation, which is linked to treatment resistance and immune evasion in the tumor microenvironment (TME).
Purpose of the Study:
- To review the characteristics of PANoptosis and its regulatory molecules.
- To examine the immunomodulatory functions of PANoptosis within the TME.
- To explore therapeutic strategies targeting PANoptosis for cancer treatment.
Main Methods:
- Literature review summarizing research on PANoptosis.
- Analysis of PANoptosis's role in immune cell interactions within the TME.
- Discussion of therapeutic implications, including immunotherapy and combination therapies.
Main Results:
- PANoptosis is regulated by the assembly of specific PANoptosomes (NLRP12, ZBP1, AIM2, RIPK1).
- It plays a dual role in the TME: mediating anti-tumor immunity and enabling tumor immune evasion.
- PANoptosis induction can create a positive feedback loop for immune activation.
Conclusions:
- PANoptosis is a critical factor in immune remodeling within the TME.
- Targeting PANoptosis offers promising avenues for novel cancer immunotherapies and combination treatments.
- Future research may lead to personalized cancer therapies by modulating PANoptosis.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.